Publications by authors named "Gabriella Di Virgilio"
The year 2022 was marked by the development of numerous new treatments for refractory myasthenia gravis. The link between epilepsy and cerebrovascular disorder was studied and lamotrigine discovered to be the optimal treatment choice for epilepsy secondary to stroke to prevent mortality on patient of 45 years and older. New randomized study finally demonstrated the utility of thrombectomy in selected patients with basilar artery occlusion.
View Article and Find Full Text PDFArticle Synopsis
- In 2020, significant advancements were made in blood biomarkers for Alzheimer's disease, improving diagnosis and management.
- New research focused on the treatment of status epilepticus and epilepsy, especially in women of childbearing age, alongside updated Swiss guidelines for acute stroke management and prevention.
- Progress was noted in managing NeuroMyelitis Optica Spectrum Disorder (NMO-SD), neurological presentations related to COVID-19, new treatments for migraines, and pharmacological therapies for Parkinson's disease.
Thrombolysis and late thrombectomy can be performed in case of compatible radiological imaging. Anti-CGRP monoclonal antibodies seem more effective for the treatment of migraine. Siponimod can reduce significantly disability progression in secondarily progressive MS.
View Article and Find Full Text PDF